Results 51 to 60 of about 100,112 (246)
Titanium dioxide-assisted photocatalytic induction of prophages to lytic cycle [PDF]
The investigations on the kinetics of photocatalytic inactivation of bacteriophages, lactic bacteria and lysogenic lactic bacteria have shown that the rate of bacterial inactivation is ca. 10 times less than the inactivation of bacteriophages. Titania-assisted photorelease of bacteriophages from lysogenic bacteria proves that photogenerated reactive ...
N. A. Belyasova+5 more
openaire +3 more sources
Inhibition of the Epstein–Barr virus lytic cycle by protoapigenone
Epstein–Barr virus (EBV) expresses two transcription factors, Rta and Zta, during the immediate–early stage of the lytic cycle to activate the transcription of early and late genes. This study finds that 0.31 mM protoapigenone fromThelypteris torresiana(Gaud.) inhibits the expression of EBV lytic proteins, including Rta, Zta, EA-D and VCA, in P3HR1 ...
Chao Ping Tung+6 more
openaire +3 more sources
Objective The aims of this research were to determine the genomic properties of BI-EHEC to control Enterohemorrhagic Escherichia coli (EHEC), which was isolated from previous study.
Marta Nisita Dewanggana+2 more
doaj +1 more source
Epstein-Barr virus transcription factor Zta acts through distal regulatory elements to directly control cellular gene expression [PDF]
Lytic replication of the human gamma herpes virus Epstein-Barr virus (EBV) is an essential prerequisite for the spread of the virus. Differential regulation of a limited number of cellular genes has been reported in B-cells during the viral lytic ...
Alison J. Sinclair+77 more
core +1 more source
Inhibition of the Epstein-Barr Virus Lytic Cycle by Andrographolide
Andrographis paniculata NEES is a medicinal plant that is commonly used in Asia. This work demonstrates that 25 microg/ml of ethanolic extract from A. paniculata (EEAP) and 5 microg/ml of andrographolide, a bioactive compound in EEAP, effectively inhibit the expression of Epstein-Barr virus (EBV) lytic proteins, Rta, Zta and EA-D, during the viral ...
Tsuey-Pin LIN+4 more
openaire +5 more sources
AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury
Hepatology, EarlyView.
Robert J. Fontana+6 more
wiley +1 more source
CD8+ T cell responses to Epstein-Barr virus (EBV) lytic cycle expressed antigens display a hierarchy of immunodominance, in which responses to epitopes of immediate-early (IE) and some early (E) antigens are more frequently observed than responses to ...
Laura L Quinn+6 more
doaj +1 more source
Reactivation of Epstein-Barr virus lytic cycle by histone deacetylase inhibitors [PDF]
Epstein-Barr virus (EBV) is closely associated with certain lymphoid and epithelial malignancies such as Burkitt lymphoma, nasopharyngeal carcinoma (NPC) and gastric carcinoma (GC).
Chiang, AKS, Hui, KF
core +1 more source
This study presents novel macrocyclic peptides with low nanomolar affinity for CD59, an immunomodulatory cell surface receptor associated with human disease. Crystallographic and structure‐activity relationship (SAR) studies reveal peptide CP‐06 mimics the binding of biologically relevant CD59 interaction partners. Dimeric and lipidated CP‐06 analogues
Jasmine K. Bickel+12 more
wiley +2 more sources
Inhibition of Epstein-Barr Virus Lytic Reactivation by the Atypical Antipsychotic Drug Clozapine
Epstein−Barr virus (EBV), a member of the Herpesviridae family, maintains a lifelong latent infection in human B cells. Switching from the latent to the lytic phase of its lifecycle allows the virus to replicate and spread. The viral lytic cycle is
Abbie G. Anderson+3 more
doaj +1 more source